Literature DB >> 19821713

Trends in the epidemiology of human G1P[8] rotaviruses: a hungarian study.

Krisztián Bányai1, Jon R Gentsch, Vito Martella, Agnes Bogdán, Viktória Havasi, Péter Kisfali, Alíz Szabó, Ilona Mihály, Péter Molnár, Béla Melegh, György Szücs.   

Abstract

Epidemiological trends of the globally most common rotavirus genotype, G1P[8], were investigated in Hungary during a 16-year period by sequencing and phylogenetic analysis of the surface antigens. Antigen shift among epidemiologically major G1P[8] strains was observed in 6 seasons, as indicated by changes in the sublineages of the G1 VP7 and the P[8] VP4 genes. The temporal clustering of some rotavirus VP4 and VP7 gene sublineages and the periodic emergence and/or resurgence of previously unrecognized rotavirus sublineages in the study population suggest a dynamic nature for these common strains. Recently established international strain surveillance networks may help to identify and track the spread of epidemiologically important rotavirus strains across countries and continents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19821713     DOI: 10.1086/605052

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Modeling rotavirus strain dynamics in developed countries to understand the potential impact of vaccination on genotype distributions.

Authors:  Virginia E Pitzer; Manish M Patel; Ben A Lopman; Cécile Viboud; Umesh D Parashar; Bryan T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

2.  Clinical and molecular observations of two fatal cases of rotavirus-associated enteritis in children in Italy.

Authors:  Maria Cristina Medici; Laura Anna Abelli; Monica Martinelli; Domenico Corradi; Icilio Dodi; Fabio Tummolo; Valeria Albonetti; Vito Martella; Giuseppe Dettori; Carlo Chezzi
Journal:  J Clin Microbiol       Date:  2011-04-27       Impact factor: 5.948

3.  Whole genome analyses of G1P[8] rotavirus strains from vaccinated and non-vaccinated South African children presenting with diarrhea.

Authors:  Nonkululeko B Magagula; Mathew D Esona; Martin M Nyaga; Karla M Stucker; Rebecca A Halpin; Timothy B Stockwell; Mapaseka L Seheri; A Duncan Steele; David E Wentworth; M Jeffrey Mphahlele
Journal:  J Med Virol       Date:  2014-05-20       Impact factor: 2.327

4.  Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq.

Authors:  Mark Zeller; John T Patton; Elisabeth Heylen; Sarah De Coster; Max Ciarlet; Marc Van Ranst; Jelle Matthijnssens
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

5.  Human G9P[8] rotavirus strains circulating in Cameroon, 1999-2000: Genetic relationships with other G9 strains and detection of a new G9 subtype.

Authors:  M D Esona; S Mijatovic-Rustempasic; K Foytich; S Roy; K Banyai; G E Armah; A D Steele; E M Volotão; M M Gomez; M F M Silva; R Gautam; O Quaye; K I Tam; J C Forbi; M Seheri; N Page; J Nyangao; V N Ndze; M Aminu; M D Bowen; J R Gentsch
Journal:  Infect Genet Evol       Date:  2013-06-14       Impact factor: 3.342

Review 6.  Review of global rotavirus strain prevalence data from six years post vaccine licensure surveillance: is there evidence of strain selection from vaccine pressure?

Authors:  Renáta Dóró; Brigitta László; Vito Martella; Eyal Leshem; Jon Gentsch; Umesh Parashar; Krisztián Bányai
Journal:  Infect Genet Evol       Date:  2014-09-16       Impact factor: 3.342

7.  Whole genome and in-silico analyses of G1P[8] rotavirus strains from pre- and post-vaccination periods in Rwanda.

Authors:  Sebotsana Rasebotsa; Peter N Mwangi; Milton T Mogotsi; Saheed Sabiu; Nonkululeko B Magagula; Kebareng Rakau; Jeannine Uwimana; Leon Mutesa; Narcisse Muganga; Didier Murenzi; Lisine Tuyisenge; Jose Jaimes; Mathew D Esona; Michael D Bowen; M Jeffrey Mphahlele; Mapaseka L Seheri; Jason M Mwenda; Martin M Nyaga
Journal:  Sci Rep       Date:  2020-08-10       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.